342 related articles for article (PubMed ID: 34668064)
1. Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.
Raina R; Chakraborty R; Davenport A; Brophy P; Sethi S; McCulloch M; Bunchman T; Yap HK
Pediatr Nephrol; 2022 Oct; 37(10):2303-2330. PubMed ID: 34668064
[TBL] [Abstract][Full Text] [Related]
2. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
Khoo BZE; Lim RS; See YP; Yeo SC
BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
[TBL] [Abstract][Full Text] [Related]
3. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study.
Di Mario F; Regolisti G; Di Maria A; Parmigiani A; Benigno GD; Picetti E; Barbagallo M; Greco P; Maccari C; Fiaccadori E
J Crit Care; 2021 Jun; 63():22-25. PubMed ID: 33611151
[TBL] [Abstract][Full Text] [Related]
4. Switching from continuous veno-venous hemodiafiltration to intermittent sustained low-efficiency daily hemodiafiltration (SLED-f) in pediatric acute kidney injury: A prospective cohort study.
Sethi SK; Raina R; Bansal SB; Soundararajan A; Dhaliwal M; Raghunathan V; Kalra M; Soni K; Mahato SK; Vadhera A; Yadav DK; Bunchman T
Hemodial Int; 2023 Jul; 27(3):308-317. PubMed ID: 37096552
[TBL] [Abstract][Full Text] [Related]
5. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
[TBL] [Abstract][Full Text] [Related]
6. Non-anticoagulation pediatric continuous renal replacement therapy methods to increase circuit life.
Raina R; Sethi S; Khooblall A; Kher V; Deshpande S; Yerigeri K; Pandya A; Nair N; Datla N; McCulloch M; Bunchman T; Davenport A
Hemodial Int; 2022 Apr; 26(2):147-159. PubMed ID: 34989465
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
[TBL] [Abstract][Full Text] [Related]
8. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
[TBL] [Abstract][Full Text] [Related]
9. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
Finkel KW; Foringer JR
Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
[TBL] [Abstract][Full Text] [Related]
10. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Arnold F; Westermann L; Rieg S; Neumann-Haefelin E; Biever PM; Walz G; Kalbhenn J; Tanriver Y
BMC Nephrol; 2020 Nov; 21(1):486. PubMed ID: 33198670
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
[TBL] [Abstract][Full Text] [Related]
13. Review of Anticoagulation in Continuous Renal Replacement Therapy.
Roe NA; Wiss AL; Volgas S; Hudson JQ
Crit Care Nurs Q; 2022 Apr-Jun 01; 45(2):144-155. PubMed ID: 35212654
[TBL] [Abstract][Full Text] [Related]
14. Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions.
Di Mario F; Regolisti G; Maggiore U; Pacchiarini MC; Menegazzo B; Greco P; Maccari C; Zambrano C; Cantarelli C; Pistolesi V; Morabito S; Fiaccadori E
Nephrol Dial Transplant; 2022 Nov; 37(12):2505-2513. PubMed ID: 35481705
[TBL] [Abstract][Full Text] [Related]
15. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal.
Berbece AN; Richardson RM
Kidney Int; 2006 Sep; 70(5):963-8. PubMed ID: 16850023
[TBL] [Abstract][Full Text] [Related]
16. A Meta-Analysis of Extracorporeal Anticoagulants in Pediatric Continuous Kidney Replacement Therapy.
Raina R; Agrawal N; Kusumi K; Pandey A; Tibrewal A; Botsch A
J Intensive Care Med; 2022 May; 37(5):577-594. PubMed ID: 33688766
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and Efficacy of Sustained Low-Efficiency Dialysis in Critically Ill Children with Severe Acute Kidney Injury.
Yadav M; Tiwari AN; Lodha R; Sankar J; Khandelwal P; Hari P; Sinha A; Bagga A
Indian J Pediatr; 2023 Apr; 90(4):355-361. PubMed ID: 35781615
[TBL] [Abstract][Full Text] [Related]
18. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
[TBL] [Abstract][Full Text] [Related]
19. Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019.
Deep A; Alexander EC; Khatri A; Kumari N; Sudheendhra K; Patel P; Joarder A; Elghuwael I
Pediatr Crit Care Med; 2024 Jan; 25(1):15-23. PubMed ID: 38169336
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation in renal replacement therapies: Why heparin should be abandoned in critical ill patients?
Musalem P; Pedreros-Rosales C; Müller-Ortiz H
Int Urol Nephrol; 2024 Apr; 56(4):1383-1393. PubMed ID: 37755609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
